Zeshen Wu
Shenzhen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Bladder Cancer Growth is Inhibited by Upregulating CircFUT8 through the METTL14/FMR1 Signaling Pathway.
Journal: Cell biochemistry and biophysics
Published: May 28, 2025
Development and internal validation of a novel nomogram for predicting lymph node invasion for prostate cancer patients undergoing extended pelvic lymph node dissection.
Journal: Frontiers in oncology
Published: March 14, 2023
Nkx2.8 promotes chemosensitivity in bladder urothelial carcinoma via transcriptional repression of MDR1.
Journal: Cell death & disease
Published: December 10, 2021
Immune checkpoint inhibitors further aggravate proteinuria in patients with metastatic renal cell carcinoma after long-term targeted therapy.
Journal: Translational andrology and urology
Published: November 17, 2021
FXR1 can bind with the CFIm25/CFIm68 complex and promote the progression of urothelial carcinoma of the bladder by stabilizing TRAF1 mRNA.
Journal: Cell death & disease
Published: October 19, 2021
What Happens to the Preserved Renal Parenchyma After Clamped Partial Nephrectomy?
Journal: European urology
Published: September 07, 2021
Role of Sam68 in Sunitinib induced renal cell carcinoma apoptosis.
Journal: Cancer medicine
Published: August 26, 2021
Neoadjuvant combination of pazopanib or axitinib and programmed cell death protein-1-activated dendritic cell-cytokine-induced killer cells immunotherapy may facilitate surgery in patients with renal cell carcinoma.
Journal: Translational andrology and urology
Published: June 23, 2021
ZHX3 promotes the progression of urothelial carcinoma of the bladder via repressing of RGS2 and is a novel substrate of TRIM21.
Journal: Cancer science
Published: November 21, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026